Johnson Fistel, PLLP is investigating potential claims for investors of Option Care Health following the company's weak Q1 2026 financial results, including only 1.3% revenue growth and a 6.3% decline in adjusted EBITDA. The company also lowered its full-year revenue and cash flow guidance, citing challenges in its chronic disease portfolio, which led to a sharp drop in its stock price. The investigation aims to determine if Option Care Health's executives complied with federal securities laws. Investors who suffered losses are encouraged to contact Johnson Fistel for possible recovery of their investments.
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Viasat and BMW Group have successfully demonstrated the first integrated automotive satellite voice call, allowing drivers to make calls directly through the car's infotainment system even in areas without cellular coverage. This advancement, utilizi...
Iran has warned it will retaliate fiercely if the US targets its infrastructure, following President Trump's threat to strike Iranian power plants and bridges next week if negotiations fail. The US recently conducted airstrikes against Iranian milita...
Solana (SOL) maintains its price in the mid-$70 range, supported by several key developments. These include Circle's recent issuance of $500 million in USDC on the Solana network, increasing liquidity and transactional demand. Additionally, instituti...
